Targeting protein kinases for cancer therapy:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Hoboken, N.J.
Wiley
c2010
|
Schlagworte: | |
Online-Zugang: | TUM01 Volltext |
Beschreibung: | Includes bibliographical references and index An expert guide to targeting protein kinases in cancer therapy. Research has shown that protein kinases can instigate the formation and spread of cancer when they transmit faulty signals inside cells. Because of this fact, pharma-ceutical scientists have targeted kinases for intensive study, and have been working to develop medicinal roadblocks to sever their malignant means of communication. Complete with full-color presentations, Targeting Protein Kinases for Cancer Therapydefines the structural features of protein kinases and examines their cellular functions. |
Beschreibung: | 1 Online-Ressource (xiii, 702 p.) |
ISBN: | 0470555289 0470555297 9780470555286 9780470555293 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV040472844 | ||
003 | DE-604 | ||
005 | 20130325 | ||
007 | cr|uuu---uuuuu | ||
008 | 121011s2010 |||| o||u| ||||||eng d | ||
020 | |a 0470555289 |c electronic bk. |9 0-470-55528-9 | ||
020 | |a 0470555297 |c electronic bk. |9 0-470-55529-7 | ||
020 | |a 9780470555286 |c electronic bk. |9 978-0-470-55528-6 | ||
020 | |a 9780470555293 |c electronic bk. |9 978-0-470-55529-3 | ||
035 | |a (OCoLC)699597274 | ||
035 | |a (DE-599)BVBBV040472844 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-91 | ||
100 | 1 | |a Matthews, David J. |e Verfasser |4 aut | |
245 | 1 | 0 | |a Targeting protein kinases for cancer therapy |c David J. Matthews, Mary E. Gerritsen |
264 | 1 | |a Hoboken, N.J. |b Wiley |c c2010 | |
300 | |a 1 Online-Ressource (xiii, 702 p.) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
500 | |a Includes bibliographical references and index | ||
500 | |a An expert guide to targeting protein kinases in cancer therapy. Research has shown that protein kinases can instigate the formation and spread of cancer when they transmit faulty signals inside cells. Because of this fact, pharma-ceutical scientists have targeted kinases for intensive study, and have been working to develop medicinal roadblocks to sever their malignant means of communication. Complete with full-color presentations, Targeting Protein Kinases for Cancer Therapydefines the structural features of protein kinases and examines their cellular functions. | ||
650 | 4 | |a Protein kinases / Inhibitors / Therapeutic use | |
650 | 4 | |a Antineoplastic agents | |
650 | 4 | |a Protein kinases | |
650 | 4 | |a Neoplasms / drug therapy | |
650 | 4 | |a Protein Kinase Inhibitors / therapeutic use | |
650 | 4 | |a Drug Discovery | |
650 | 4 | |a Drug Resistance, Neoplasm | |
650 | 4 | |a Protein Kinases / physiology | |
650 | 4 | |a Protein-Tyrosine Kinases / antagonists & inhibitors | |
650 | 0 | 7 | |a Proteinkinasen |0 (DE-588)4175996-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
689 | 0 | 2 | |a Proteinkinasen |0 (DE-588)4175996-5 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
700 | 1 | |a Gerritsen, Mary E. |e Sonstige |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 0-470-22965-9 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe, Hardcover |z 978-0-470-22965-1 |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305 |x Verlag |3 Volltext |
912 | |a ZDB-4-NLEBK | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-025320133 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305 |l TUM01 |p ZDB-4-NLEBK |q TUM_PDA_EBSCO_MED_gekauft |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804149536634961920 |
---|---|
any_adam_object | |
author | Matthews, David J. |
author_facet | Matthews, David J. |
author_role | aut |
author_sort | Matthews, David J. |
author_variant | d j m dj djm |
building | Verbundindex |
bvnumber | BV040472844 |
collection | ZDB-4-NLEBK |
ctrlnum | (OCoLC)699597274 (DE-599)BVBBV040472844 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03013nmm a2200589zc 4500</leader><controlfield tag="001">BV040472844</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20130325 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">121011s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470555289</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-55528-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0470555297</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-470-55529-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470555286</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-55528-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780470555293</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-470-55529-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)699597274</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV040472844</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-91</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Matthews, David J.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Targeting protein kinases for cancer therapy</subfield><subfield code="c">David J. Matthews, Mary E. Gerritsen</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, N.J.</subfield><subfield code="b">Wiley</subfield><subfield code="c">c2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 702 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">An expert guide to targeting protein kinases in cancer therapy. Research has shown that protein kinases can instigate the formation and spread of cancer when they transmit faulty signals inside cells. Because of this fact, pharma-ceutical scientists have targeted kinases for intensive study, and have been working to develop medicinal roadblocks to sever their malignant means of communication. Complete with full-color presentations, Targeting Protein Kinases for Cancer Therapydefines the structural features of protein kinases and examines their cellular functions.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein kinases / Inhibitors / Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein kinases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein Kinase Inhibitors / therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Discovery</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Neoplasm</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein Kinases / physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Protein-Tyrosine Kinases / antagonists & inhibitors</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Proteinkinasen</subfield><subfield code="0">(DE-588)4175996-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Proteinkinasen</subfield><subfield code="0">(DE-588)4175996-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerritsen, Mary E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">0-470-22965-9</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe, Hardcover</subfield><subfield code="z">978-0-470-22965-1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-NLEBK</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-025320133</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305</subfield><subfield code="l">TUM01</subfield><subfield code="p">ZDB-4-NLEBK</subfield><subfield code="q">TUM_PDA_EBSCO_MED_gekauft</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV040472844 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T00:24:35Z |
institution | BVB |
isbn | 0470555289 0470555297 9780470555286 9780470555293 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-025320133 |
oclc_num | 699597274 |
open_access_boolean | |
owner | DE-91 DE-BY-TUM |
owner_facet | DE-91 DE-BY-TUM |
physical | 1 Online-Ressource (xiii, 702 p.) |
psigel | ZDB-4-NLEBK ZDB-4-NLEBK TUM_PDA_EBSCO_MED_gekauft |
publishDate | 2010 |
publishDateSearch | 2010 |
publishDateSort | 2010 |
publisher | Wiley |
record_format | marc |
spelling | Matthews, David J. Verfasser aut Targeting protein kinases for cancer therapy David J. Matthews, Mary E. Gerritsen Hoboken, N.J. Wiley c2010 1 Online-Ressource (xiii, 702 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index An expert guide to targeting protein kinases in cancer therapy. Research has shown that protein kinases can instigate the formation and spread of cancer when they transmit faulty signals inside cells. Because of this fact, pharma-ceutical scientists have targeted kinases for intensive study, and have been working to develop medicinal roadblocks to sever their malignant means of communication. Complete with full-color presentations, Targeting Protein Kinases for Cancer Therapydefines the structural features of protein kinases and examines their cellular functions. Protein kinases / Inhibitors / Therapeutic use Antineoplastic agents Protein kinases Neoplasms / drug therapy Protein Kinase Inhibitors / therapeutic use Drug Discovery Drug Resistance, Neoplasm Protein Kinases / physiology Protein-Tyrosine Kinases / antagonists & inhibitors Proteinkinasen (DE-588)4175996-5 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 s Therapie (DE-588)4059798-2 s Proteinkinasen (DE-588)4175996-5 s 1\p DE-604 Gerritsen, Mary E. Sonstige oth Erscheint auch als Druck-Ausgabe, Hardcover 0-470-22965-9 Erscheint auch als Druck-Ausgabe, Hardcover 978-0-470-22965-1 http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305 Verlag Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Matthews, David J. Targeting protein kinases for cancer therapy Protein kinases / Inhibitors / Therapeutic use Antineoplastic agents Protein kinases Neoplasms / drug therapy Protein Kinase Inhibitors / therapeutic use Drug Discovery Drug Resistance, Neoplasm Protein Kinases / physiology Protein-Tyrosine Kinases / antagonists & inhibitors Proteinkinasen (DE-588)4175996-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Therapie (DE-588)4059798-2 gnd |
subject_GND | (DE-588)4175996-5 (DE-588)4073781-0 (DE-588)4059798-2 |
title | Targeting protein kinases for cancer therapy |
title_auth | Targeting protein kinases for cancer therapy |
title_exact_search | Targeting protein kinases for cancer therapy |
title_full | Targeting protein kinases for cancer therapy David J. Matthews, Mary E. Gerritsen |
title_fullStr | Targeting protein kinases for cancer therapy David J. Matthews, Mary E. Gerritsen |
title_full_unstemmed | Targeting protein kinases for cancer therapy David J. Matthews, Mary E. Gerritsen |
title_short | Targeting protein kinases for cancer therapy |
title_sort | targeting protein kinases for cancer therapy |
topic | Protein kinases / Inhibitors / Therapeutic use Antineoplastic agents Protein kinases Neoplasms / drug therapy Protein Kinase Inhibitors / therapeutic use Drug Discovery Drug Resistance, Neoplasm Protein Kinases / physiology Protein-Tyrosine Kinases / antagonists & inhibitors Proteinkinasen (DE-588)4175996-5 gnd Krebs Medizin (DE-588)4073781-0 gnd Therapie (DE-588)4059798-2 gnd |
topic_facet | Protein kinases / Inhibitors / Therapeutic use Antineoplastic agents Protein kinases Neoplasms / drug therapy Protein Kinase Inhibitors / therapeutic use Drug Discovery Drug Resistance, Neoplasm Protein Kinases / physiology Protein-Tyrosine Kinases / antagonists & inhibitors Proteinkinasen Krebs Medizin Therapie |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=310305 |
work_keys_str_mv | AT matthewsdavidj targetingproteinkinasesforcancertherapy AT gerritsenmarye targetingproteinkinasesforcancertherapy |